PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.79 +0.04 (+2.29%)
At close: Oct 2, 2026 · 4:00 PM EDT

PMV Pharmaceuticals (PMVP) Cash & Current Investments (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Cash & Current Investments of $79.43 million for Q2 2026, down 44.2% from $142.27 million a year earlier and down 15.1% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, PMV Pharmaceuticals' Cash & Current Investments came in at $112.94 million, down 33.3% from FY2024.

  • Annual Cash & Current Investments has declined for five consecutive years, with a five-year compound annual growth rate of -20.8% (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Cash & Current Investments was $169.45 million in FY2024 (-16.5%), $203.06 million in FY2023 (-15.8%), $241.05 million in FY2022 (-18.9%) and $297.16 million in FY2021 (-17.8%).
  • The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments in data going back to Q4 2019.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last eight quarters, with an average decline of 28.3% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2024, with growth of 13.8%; the weakest was Q2 2026, with a decline of 44.2%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $93.55 million (Q1 2026), $112.94 million (Q4 2025) and $129.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 PMV Pharmaceuticals 95.69 Mn -319.48 Mn - 79.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.43 Mn
Mar 31, 2026 93.55 Mn
Dec 31, 2025 112.94 Mn
Sep 30, 2025 129.25 Mn
Jun 30, 2025 142.27 Mn
Mar 31, 2025 160.39 Mn
Dec 31, 2024 169.45 Mn
Sep 30, 2024 182.84 Mn
Jun 30, 2024 212.92 Mn
Mar 31, 2024 197.94 Mn
Dec 31, 2023 203.06 Mn
Sep 30, 2023 201.92 Mn
Jun 30, 2023 187.09 Mn
Mar 31, 2023 229.43 Mn
Dec 31, 2022 241.05 Mn
Sep 30, 2022 258.86 Mn
Jun 30, 2022 277.43 Mn
Mar 31, 2022 282.99 Mn
Dec 31, 2021 297.16 Mn
Sep 30, 2021 307.65 Mn
API Access

PMV Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PMVP&period=max&api_key=YOUR_API_KEY